Aminex PLC
02 June 2005
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN PART OR IN WHOLE IN OR INTO THE
UNITED STATES, AUSTRALIA, CANADA, JAPAN OR SOUTH AFRICA
For immediate release
2nd June, 2005
Aminex PLC ("Aminex" or the "Company")
Proposed Placing and Open Offer to raise up to Stg£6.6 million (€9.7 million)
Highlights
• Intention to place 50,800,000 Ordinary Shares at Stg 8.7p per share to
raise approximately Stg£4.4 million (€6.5 million) (the "Placing");
• Intention to launch an Open Offer to qualifying shareholders of
24,973,433 Ordinary Shares on the basis of 1 new Ordinary Share for every 4
existing Ordinary Shares at Stg 8.7p per share to raise up to Stg£2.2 million
(the "Open Offer"); and
• Proceeds of the proposed Placing and Open Offer to fund capital
expenditure on the Group's Tanzanian and North Korean acreage and other
opportunities.
The Board of Aminex is pleased to announce that Aminex intends to conditionally
place firm 50,800,000 Ordinary Shares ("Placing Shares") with institutional and
other investors, representing approximately 51% of the existing Issued Share
Capital on 3 June 2005. The gross proceeds of the Placing will amount to
approximately Stg£4.4 million (€6.5 million) and are intended to be used to fund
capital expenditure for the Group's Tanzanian and North Korean acreage and other
opportunities.
The Placing is being arranged by Oriel and Davy. The Placing has not been
underwritten and is conditional on Oriel, Davy and the Company entering into a
placing agreement (the "Placing Agreement") which is expected to happen on 3
June 2005. In addition, the Placing will be conditional on shareholder approval,
the Placing Agreement becoming unconditional in all respects and admission of
the Placing Shares and the Open Offer Shares to the official lists of the Irish
Stock Exchange and the UK Listing Authority and to trading on the main markets
of the Irish Stock Exchange and the London Stock Exchange.
In addition, the Company today announces that, subject to entering into the
Placing Agreement, it intends to launch an Open Offer to qualifying shareholders
of 24,973,433 Ordinary Shares ("Open Offer Shares") on the basis of 1 new
Ordinary Share for every 4 existing Ordinary Shares at Stg 8.7p per share to
raise up to Stg£2.2 million on 3 June 2005.
A further announcement will be made in due course.
For Further Information:
Aminex PLC
(+44 20 7240 1600)
Brian Hall
Oriel Securities Limited
(+44 20 7710 7600)
Simon Bragg/Scott Richardson Brown
Davy Corporate Finance Limited
(+353 1 679 6363)
Hugh McCutcheon/Fergal Meegan
Oriel Securities Limited (''Oriel'') (which is regulated in the UK by the
Financial Services Authority) and Davy Corporate Finance Limited and J & E Davy
(collectively ''Davy'') (each of which are regulated in Ireland by the Irish
Financial Services Regulatory Authority) are acting exclusively for Aminex in
connection with the requirements of the Irish Stock Exchange and the UK Listing
Authority and for no one else and will not be responsible to any other person
for providing the protection afforded to customers of Oriel and Davy nor for
providing advice in connection with this announcement.
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.